Stock Analysis of Chromadex Corp (CDXC) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code CDXC
Close 2.76
Change -0.070 / 2.47 %
Volume 161820
Vol Change -12205.00 / 7.01 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Mild Growth
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Good Stability


Fundamental View of Chromadex Corp


Highs/Lows of Chromadex Corp
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week3.12 11.54 % 0.513 % 3.11552.728-May-2429-May-24
Two Week3.3 16.36 % 0.486 % 3.38572.720-May-2429-May-24
One Month3.54 22.03 % 4.80 % 3.97992.706-May-2429-May-24
Three Month1.67 65.27 % 3.56 % 4.651.5705-Apr-2407-Mar-24
Six Months1.39 98.56 % 15.54 % 4.651.3205-Apr-2413-Dec-23
One year1.41 95.74 % 26.26 % 4.651.2505-Apr-2423-Oct-23
Two year1.9 45.26 % 27.72 % 4.651.2305-Apr-2412-Oct-22
Five year3.98 30.65 % 91.77 % 4.651.1505-Apr-2427-Sep-22
Ten year4.56 39.47 % 174.36 % 23.661.1525-Feb-2127-Sep-22


Technical View of Chromadex Corp






Charts of Chromadex Corp


Returns of Chromadex Corp with Peers
Period / StockCDXCSPPICHRSSMLR
1 Week-11.54%0%-4.71%25.77%
1 Mth-22.03%7.29%-7.14%14.88%
3 Mth65.27%5.64%-20.18%-37.82%
6mth98.56%47.14%-14.55%-23.90%
1 Year95.74%27.16%-55.50%6.69%
2 Year45.26%-68.01%-75.20%5.28%
5 Years-30.65%-95.16%-90.37%-33.36%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Chromadex Corp with Peers
Ratio / StockCDXCSPPICHRSSMLR
PE-58.75-3.06-3.295263.68
P/B7.415.55-1.251645.16
ROA-6.55-63.72-10.4128.01
ROE-12.61-181.09031.25
Debt To Equity0.02471.06-2.470.0013
Revenue83370.00 K
15.71 %
10114.00 K
17142272 %
257244 K
21.89 %
66922.00 K
18.06 %
Net Income-6470.00 K
60.88 %
-78104.00 K
50.76 %
-237892.00 K
18.46 %
19578.00 K
36.67 %


Technicals of Chromadex Corp with Peers
Technical / StockCDXCSPPICHRSSMLR-
ADX25.3318.6924.9034.58
CMF-0.2020.0296-0.195-0.204
MFI29.2067.5060.5872.36
RSI34.0556.7936.4259.42
MACD Abv SignalFalseTrueFalseTrue
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MATrueTrueFalseFalse-


About : Chromadex Corp


Address : 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024
Tel : 310 388 6706
URL : https://www.chromadex.com
Code : CDXC, ISIN : US1710774076, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 15_Jul_2008
Employee Count : 106

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)